A Conscious Dog Model for Assessing the Absorption, Enterocyte‐Based Metabolism, and Intestinal Lymphatic Transport of Halofantrine
- 1 October 2001
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 90 (10) , 1599-1607
- https://doi.org/10.1002/jps.1110
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The formulation of Halofantrine as either non-solubilising PEG 6000 or solubilising lipid based solid dispersions: Physical stability and absolute bioavailability assessmentInternational Journal of Pharmaceutics, 2000
- Metabolism of halofantrine to its equipotent metabolite, desbutylhalofantrine, is decreased when orally administered with ketoconazoleJournal of Pharmaceutical Sciences, 1998
- Uptake of drugs into the intestinal lymphatics after oral administrationAdvanced Drug Delivery Reviews, 1997
- A physicochemical Basis for the Effect of Food on the Absolute Oral Bioavailability of HalofantrineJournal of Pharmaceutical Sciences, 1996
- Lymphatic Transport of Halofantrine in the Triple-Cannulated Anesthetized Rat Model: Effect of Lipid Vehicle DispersionJournal of Pharmaceutical Sciences, 1996
- Lymphatic Transport of Halofantrine in the Conscious Rat When Administered as Either the Free Base or the Hydrochloride Salt: Effect of Lipid Class and Lipid Vehicle DispersionJournal of Pharmaceutical Sciences, 1996
- A simplified liquid chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditionsJournal of Pharmaceutical and Biomedical Analysis, 1995
- HalofantrineDrugs, 1992
- Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug moleculesInternational Journal of Pharmaceutics, 1986
- Lymphatic appearance of DDT in thoracic or mesenteric lymph duct cannulated ratsInternational Journal of Pharmaceutics, 1985